The AlphaLISA™ SureFire® Biotin-Free Human and Mouse Total Androgen Receptor assay is a sandwich immunoassay for quantitative detection of total Androgen Receptor in cellular lysates using Alpha Technology.
| Feature | Specification |
|---|---|
| Application | Cell Signaling |
| Protocol Time | 2h at RT |
| Sample Volume | 10 µL |
The AlphaLISA™ SureFire® Biotin-Free Human and Mouse Total Androgen Receptor assay is a sandwich immunoassay for quantitative detection of total Androgen Receptor in cellular lysates using Alpha Technology.
Loading...
The Androgen Receptor (AR) is a ligand-activated nuclear receptor and transcription factor that mediates the biological effects of androgens including testosterone and dihydrotestosterone (DHT). Upon ligand binding, AR undergoes conformational change, dissociates from heat shock proteins, dimerizes, and translocates to the nucleus where it binds androgen response elements (AREs) to regulate transcription of genes controlling cell growth, differentiation, and metabolism. AR signaling is essential for normal male sexual development and prostate gland function. AR is the central driver of prostate cancer progression, and androgen deprivation therapy (ADT) targeting AR signaling remains the cornerstone of advanced prostate cancer treatment. AR Total antibodies detect all forms of the androgen receptor protein, including full-length AR, splice variants, and post-translationally modified species, providing a comprehensive measure of total cellular AR abundance. This pan-AR detection is critical for understanding overall AR expression levels across disease states, treatment conditions, and experimental models of androgen signaling.
The AlphaLISA SureFire Biotin-Free Human and Mouse Total Androgen Receptor Detection Kit is a sandwich immunoassay for the quantitative detection of total androgen receptor in cellular lysates, using Alpha Technology.
Formats:
AlphaLISA SureFire Biotin Free kits are compatible with:
AlphaLISA SureFire Biotin Free kits can be used for:
The Total-AlphaLISA SureFire Biotin Free assay measures the expression level of a target protein in a biological sample (e.g. cell lysate).
The Total-AlphaLISA SureFire Biotin Free assay uses two antibodies which recognize two different distal epitopes on the target protein. AlphaLISA assays require two bead types: Acceptor and Donor Beads. Acceptor Beads are coated with a proprietary CaptSure™ agent to specifically immobilize the assay specific antibody, labeled with a CaptSure tag. Donor Beads are coated with a proprietary CaptSure3 agent to capture one of the detection antibodies, which is labeled with the CaptSure3 tag. In the presence of target protein, the two antibodies bring the Donor and Acceptor Beads in close proximity whereby the singlet oxygen transfers energy to excite the Acceptor Bead, allowing for the generation of a luminescent Alpha signal. The amount of light emission is directly proportional to the quantity of protein present in the sample.
The two-plate protocol involves culturing and treating the cells in a 96-well plate before lysis, then transferring lysates into a 384-well OptiPlate™ plate before the addition of Total-AlphaLISA SureFire Biotin Free detection reagents. This protocol enables cell viability and confluence to be monitored. In addition, lysates from a single well can be used to measure multiple targets.
Detection of Total target protein with AlphaLISA SureFire Biotin Free reagents can be performed in a single plate used for culturing, treatment, and lysis. No washing steps are required. This HTS designed protocol allows for miniaturization while maintaining robust AlphaLISA SureFire quality.
LNCaP cells were seeded in a 96-well plate (60,000 cells/well) in complete medium and incubated overnight at 37°C, 5% CO2. Cells were treated with increasing concentrations of ARV-110 for 24 hours.
After treatment, the cells were lysed with 100 µL of Lysis Buffer for 10 minutes at RT with shaking (350 rpm). Lysates were further diluted and AR and ERK Total levels were evaluated using respective AlphaLISA SureFire Biotin Free assays. For the detection step, 10 µL of cell lysate (approximately 1,200 cells) was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor mix and incubated for 1 hour at RT. Finally, 5 µL of Donor mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.
As expected, ARV-110 induced a dose dependent decrease in AR levels with no significant changes in ERK Total levels.
MCF7 cells were seeded in a 96-well plate (40,000 cells/well) in complete medium and incubated overnight at 37°C, 5% CO2. Cells were treated with increasing concentrations of ARV-110 for 24 hours.
After treatment, the cells were lysed with 100 µL of Lysis Buffer for 10 minutes at RT with shaking (350 rpm). AR and ERK Total levels were evaluated using respective AlphaLISA SureFire Biotin Free assays. For the detection step, 10 µL of cell lysate (approximately 4,000 cells) was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor mix and incubated for 1 hour at RT. Finally, 5 µL of Donor mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.
As expected, ARV-110 induced a dose dependent decrease in AR levels with no significant changes in ERK Total levels.
Adherent cells were seeded in a 96-well plate (40,000 cells/well) in complete medium and incubated overnight. Cells were lysed with 100 µL Lysis Buffer. Suspension cells were harvested, spun down and lysed with Lysis Buffer at a density of 0.5 x 106 cells/mL.
AR levels were evaluated using the AlphaLISA SureFire Biotin Freeassay. For the detection step, 10 µL of cell lysate (4,000 adherent and 5,000 suspension cells) was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor Mix and incubated for 1 hour at RT. Finally, 5 µL of Donor Mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.
AR expression was detected in various cell lines. Elevated levels were observed in LNCaP cells. No expression was detected in PC3 cells (AR negative cell line).
Cell lysate was prepared from LNCaP cells cultured to confluence in a T175 flask and lysed with 8 mL of Lysis Buffer for 10 minutes at RT with shaking.
Lysate was serially diluted and AR levels were evaluated using the AlphaLISA SureFire Biotin Free assay. For the detection step, 10 µL of lysate was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor mix and incubated for 1 hour at room temperature. Finally, 5 µL of Donor mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.
Approximate number of cells per datapoint is indicated. The dotted line represents assay background. The assay can detect AR expression in less than 100 cells.
| Application |
Cell Signaling
|
|---|---|
| Automation Compatible |
Yes
|
| Brand |
AlphaLISA SureFire Biotin-Free
|
| Detection Modality |
Alpha
|
| Product Group |
Kit
|
| Protocol Time |
2h at RT
|
| Sample Volume |
10 µL
|
| Shipping Conditions |
Shipped in Blue Ice
|
| Target |
Androgen
|
| Target Class |
Phosphoproteins
|
| Target Species |
Human
Mouse
|
| Technology |
Alpha
|
| Therapeutic Area |
Oncology
|
| Unit Size |
50,000 Assay Points
|
Are you looking for resources, click on the resource type to explore further.
The definitive guide for setting up a successful AlphaLISA SureFire Ultra assay
Several biological processes are regulated by...
Loading...
We are here to answer your questions.